Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
From the Strasbourg Medical School, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, Cedex, France (P.M.M.); and Mayo Medical School, Rochester, Minnesota (G.W.V.).
Paul Michel
PM
Mertes
Gerald W
GW
Volcheck
D000707:Anaphylaxis / Q000453:epidemiology* / Q000209:etiology*; D000732:Androstanols / Q000009:adverse effects*; D001279:Atracurium / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects*; D000077123:Rocuronium; D013390:Succinylcholine / Q000009:adverse effects*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D001279:Atracurium; D013390:Succinylcholine; D000077123:Rocuronium